APO LMV 150 (Lamivudine 150 mg)
This pill with imprint "APO LMV 150" is White, Four-sided and has been identified as Lamivudine 150 mg. It is manufactured by Apotex Inc..
Lamivudine is used in the treatment of hepatitis b; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- APO LMV 150
- 150 mg
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Apotex Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
More about lamivudine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews – Add your own review/rating
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.